| Genome-wide association study reveals genetic risk underlying Parkinson's disease J Simón-Sánchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ... Nature genetics 41 (12), 1308-1312, 2009 | 2262 | 2009 |
| SNCA variants are associated with increased risk for multiple system atrophy SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 327 | 2009 |
| Rituximab in membranous nephropathy P Gauckler, JI Shin, F Alberici, V Audard, A Bruchfeld, M Busch, ... Kidney international reports 6 (4), 881-893, 2021 | 70 | 2021 |
| Rituximab in adult minimal change disease and focal segmental glomerulosclerosis-What is known and what is still unknown? P Gauckler, JI Shin, F Alberici, V Audard, A Bruchfeld, M Busch, ... Autoimmunity reviews 19 (11), 102671, 2020 | 64 | 2020 |
| Incidence, clinical features, and outcomes of late‐onset neutropenia from rituximab for autoimmune disease R Zonozi, ZS Wallace, K Laliberte, NR Huizenga, JM Rosenthal, EP Rhee, ... Arthritis & Rheumatology 73 (2), 347-354, 2021 | 37 | 2021 |
| Combination of rituximab, low-dose cyclophosphamide, and prednisone for primary membranous nephropathy: a case series with extended follow up R Zonozi, K Laliberte, NR Huizenga, JK Rosenthal, A Jeyabalan, ... American Journal of Kidney Diseases 78 (6), 793-803, 2021 | 36 | 2021 |
| Treatment of aggressive antineutrophil cytoplasmic antibody–associated vasculitis with eculizumab N Huizenga, R Zonozi, J Rosenthal, K Laliberte, JL Niles, FB Cortazar Kidney International Reports 5 (4), 542-545, 2020 | 31 | 2020 |
| Elevated vancomycin trough levels in a tertiary health system: frequency, risk factors, and prognosis R Zonozi, A Wu, JI Shin, A Secora, J Coresh, LA Inker, AR Chang, ... Mayo Clinic Proceedings 94 (1), 17-26, 2019 | 29 | 2019 |
| T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19 R Zonozi, LC Walters, A Shulkin, V Naranbhai, P Nithagon, G Sauvage, ... Science translational medicine 15 (724), eadh4529, 2023 | 28 | 2023 |
| Renal involvement in antineutrophil cytoplasmic antibody–associated vasculitis R Zonozi, JL Niles, FB Cortazar Rheumatic Disease Clinics 44 (4), 525-543, 2018 | 25 | 2018 |
| A 7.5‐Mb duplication at chromosome 11q21‐11q22. 3 is associated with a novel spastic ataxia syndrome JO Johnson, G Stevanin, J van de Leemput, DG Hernandez, S Arepalli, ... Movement Disorders 30 (2), 262-266, 2015 | 16 | 2015 |
| Real-world experience with avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis R Zonozi, F Aqeel, D Le, FB Cortazar, J Thaker, MJZ Ramirez, SES Cortes, ... Kidney International Reports 9 (6), 1783-1791, 2024 | 15 | 2024 |
| Eculizumab and Complement Activation in Anti− glomerular Basement Membrane Disease P Nithagon, F Cortazar, SI Shah, A Weins, K Laliberte, A Jeyabalan, ... Kidney International Reports 6 (10), 2713-2717, 2021 | 15 | 2021 |
| Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial R Zonozi, FB Cortazar, A Jeyabalan, G Sauvage, P Nithagon, ... Annals of the Rheumatic Diseases 83 (3), 351-359, 2024 | 13 | 2024 |
| Treatment of gemcitabine-induced thrombotic microangiopathy followed by gemcitabine rechallenge with eculizumab O Efe, L Goyal, A Galway, AX Zhu, JL Niles, R Zonozi Kidney International Reports 6 (5), 1464-1468, 2021 | 13 | 2021 |
| Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: an observational cohort study C Cook, A Jorge, X Fu, J Niles, A Jeyabalan, R Zonozi, JH Stone, Y Zhang, ... Seminars in arthritis and rheumatism 51 (6), 1180-1185, 2021 | 8 | 2021 |
| Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders L Yockey, S Dowst, R Zonozi, N Huizenga, P Murphy, K Laliberte, ... BMC Women's Health 21, 1-7, 2021 | 8 | 2021 |
| COVID-19 recovery without B cells or antibodies in patients receiving rituximab for autoimmune disease N Huizenga, R Charles, R Zonozi, A Jeyabalan, JL Niles IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD) 15 (2), 159-160, 2021 | 5 | 2021 |
| Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan F Aqeel, R Zonozi, A Jeyabalan, G Sauvage, JL Niles, D Geetha RMD open 9 (3), e003435, 2023 | 3 | 2023 |
| Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Based on B Cell Reconstitution vs. a Serologic ANCA Flare (MAINTANCAVAS): PO1422 R Zonozi, A Jeyabalan, P Nithagon, KA Laliberte, FB Cortazar, J Niles, ... Journal of the American Society of Nephrology 32 (10S), 450, 2021 | 3 | 2021 |
